Despite such great efforts to discover new biomarkers for PCa detection and the promising perspectives, no biomarker has so far been able to replace PSA in clinical practice for PCa screening, highlighting the need to pursue research in this field. The gene discussed is KLK3; the disease is posterior cortical atrophy.